Karen M Gisslen, CNM Advanced Practice Midwife Medicare: Accepting Medicare Assignments Practice Location: 1989 Miamisburg Centerville Rd, Suite 204, Centerville, OH 45459 Phone: 937-401-6822 Fax: 937-401-6935 |
News Archive
Millennium: The Takeda Oncology Company and, Takeda Pharmaceutical Company Limited today announced that the Committee for Medicinal Products for Human Use of the European Medicines Agency has issued a positive opinion for conditional approval of brentuximab vedotin for two indications.
Irritability is frequently the main presenting complaint of perimenopausal and postmenopausal women; yet, studies specifically researching on irritability in this population are lacking.
Genentech and Roche today announced that a randomized Phase III study of Avastin™ (bevacizumab) plus the FOLFOX4 chemotherapy regimen (oxaliplatin/5-FU/leucovorin), compared to FOLFOX4 alone, in second-line metastatic colorectal cancer patients achieved its primary endpoint of improving overall survival.
Not so meaningless, however, are recent decisions of several states to resist what ought to be some of the less controversial aspects of ObamaCare. They're refusing to set up easy-to-use exchanges that would help residents make insurance choices. And they're turning down a Medicaid expansion, which will deny insurance to millions who can't afford coverage and shift the cost of their care to people who have it (7/11).
› Verified 7 days ago